Abstract

Multiple sclerosis is an extremely heterogeneous disease and, despite intensive research, no selective biomarkers have been identified for this pathology, and therefore its diagnosis in the early stages is still challenging. One of the most powerful tools for studying the pathogenesis of multiple sclerosis is the multi-omics approach, which makes it possible to characterize cells involved in the disease progression in the most detailed and versatile way. This review will describe the current directions of research in multiple sclerosis using high-throughput technologies. Also, an assessment of the demand for the use of a multi-omics approach was carried out.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.